US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

0.9984

+0.184722.70%

Post-market: 0.9785-0.0199-1.99%16:26 EDT

Volume:196.81K

Turnover:178.51K

Market Cap:2.09M

PE:-0.04

High:1.00

Open:0.8183

Low:0.7800

Close:0.8137

52wk High:52.40

52wk Low:0.5949

Shares:2.09M

Float Shares:1.78M

Volume Ratio:3.43

T/O Rate:11.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-24.1200

EPS(LYR):-30.3477

ROE:-119.72%

ROA:-55.21%

PB:0.25

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Psychedelic: Clearmind reports additional CMND-100 safety results

BRIEF-Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile Of Cmnd-100 In Ongoing Phase I/Iia Clinical Trial

Clearmind Medicine Reports Positive Safety Results for CMND-100 in Alcohol Use Disorder Trial

Clearmind Medicine Inc - Safety Data Show No Serious Adverse Events in Second Cohort

THOMSON REUTERS

Clearmind Medicine Inc - Announces Positive Safety Results From Phase I/Iia Trial

THOMSON REUTERS

Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial

BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI

BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery

Clearmind Medicine Enters Into Development Agreement to Advance Intranasal Formulation for Its Proprietary Non-Hallucinogenic Neuroplastogen Meai

THOMSON REUTERS

Polyrizon Partners with Clearmind to Develop Intranasal MEAI Formulation

Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

THOMSON REUTERS

Clearmind Medicine Issues $2.5 Million in Convertible Promissory Notes

Clearmind Medicine gibt Ausgabe von Wandelanleihen im Gesamtwert von 2,5 Millionen US-Dollar bekannt

Clearmind Medicine welcomes inclusion of MEAI in bipartisan legislation

Clearmind Medicine erzielt Durchbruch mit MEAI in US-Gesetz für innovative Veteranen-Therapien

Psychedelic: Clearmind completes second cohort treatment for CMND-100 trial

BRIEF-Clearmind Medicine Inc - Topline Results From Second Cohort Of CMND-100 Expected In Coming Months

Clearmind Medicine Inc - Topline Results From Second Cohort of Cmnd-100 Expected in Coming Months

THOMSON REUTERS

Clearmind Medicine Completes Second Cohort Treatment in Phase I/IIa Trial for Alcohol Use Disorder Drug

Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CMND/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":0.9984,"timestamp":1774900800000,"preClose":0.8137,"halted":0,"volume":196810,"hourTrading":{"tag":"盘后","latestPrice":0.9785,"preClose":0.9984,"latestTime":"16:26 EDT","volume":6080,"amount":5838.5709216000005,"timestamp":1774902417217,"change":-0.0199,"changeRate":-0.019932,"amplitude":0.078526},"delay":0,"changeRate":0.22698783335381587,"floatShares":1776000,"shares":2088800,"eps":-24.12,"marketStatus":"Post-Mkt","change":0.1847,"latestTime":"03-30 16:32:09 EDT","open":0.8183,"high":1,"low":0.78,"amount":178514.240975,"amplitude":0.27037,"askPrice":0.9785,"askSize":800,"bidPrice":0.969,"bidSize":27,"shortable":3,"etf":0,"ttmEps":-24.12,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774915200000},"marketStatusCode":4,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":0.8137,"preHourTrading":{"tag":"盘前","latestPrice":0.83,"preClose":0.8137,"latestTime":"09:06 EDT","volume":1329,"amount":1092.6489123000001,"timestamp":1774875994864,"change":0.0163,"changeRate":0.020032,"amplitude":0.086027},"postHourTrading":{"tag":"盘后","latestPrice":0.9785,"preClose":0.9984,"latestTime":"16:26 EDT","volume":6080,"amount":5838.5709216000005,"timestamp":1774902417217,"change":-0.0199,"changeRate":-0.019932,"amplitude":0.078526},"volumeRatio":3.434298},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":1776000,"roa":"-55.21%","roe":"-119.72%","lyrEps":-30.347721,"volumeRatio":3.434298,"shares":2088800,"dividePrice":0,"high":1,"amplitude":0.27037,"preClose":0.8137,"low":0.78,"week52Low":0.5949,"pbRate":"0.25","week52High":52.4,"institutionHeld":0,"latestPrice":0.9984,"committee":-0.934704,"eps":-24.12,"divideRate":0,"volume":196810,"delay":0,"ttmEps":-24.12,"open":0.8183,"prevYearClose":1.81,"prevWeekClose":0.8137,"prevMonthClose":1.13,"prevQuarterClose":1.81,"fiveDayClose":0.6715,"twentyDayClose":1.22,"sixtyDayClose":1.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-15","symbol":"CMND","defaultRemindTime":1765809000000,"type":"split","dateTimestamp":1765774800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2026-03-27","current":-0.033735,"percent":0.989405,"low":-85.590719,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"high":-0.132425,"avg":-7.921703,"sd":19.082954,"marketCap":1539450},"quantilePoints":[{"date":"2021-04-01","current":-11.587771,"twenty":-37.438053,"median":-9.227851,"eighty":-5.327909,"marketCap":2829836.18},{"date":"2021-04-09","current":-11.587771,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":2832089.53},{"date":"2021-04-16","current":-11.587771,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":2845184.59},{"date":"2021-04-23","current":-17.615217,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":4326958.35},{"date":"2021-04-30","current":-17.615217,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":4388776.06},{"date":"2021-05-07","current":-17.615217,"twenty":-37.438053,"median":-13.367717,"eighty":-5.327909,"marketCap":4452312.37},{"date":"2021-05-14","current":-17.615217,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":4466989.71},{"date":"2021-05-21","current":-17.615217,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":4486524.55},{"date":"2021-05-28","current":-78.078262,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":19823707.07},{"date":"2021-06-04","current":-75.221742,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":19088186.32},{"date":"2021-06-11","current":-71.413047,"twenty":-37.438053,"median":-16.38144,"eighty":-5.327909,"marketCap":18026757.96},{"date":"2021-06-18","current":-69.508697,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":17101728.27},{"date":"2021-06-25","current":-77.126088,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":19258243.57},{"date":"2021-07-02","current":-77.809745,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":27345681.85},{"date":"2021-07-09","current":-81.267955,"twenty":-45.757607,"median":-17.615217,"eighty":-5.327909,"marketCap":28278833.84},{"date":"2021-07-16","current":-82.132509,"twenty":-57.232721,"median":-17.615217,"eighty":-5.327909,"marketCap":28316450.35},{"date":"2021-07-23","current":-82.99706,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":28633395.33},{"date":"2021-07-30","current":-84.726165,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":29489162.42},{"date":"2021-08-06","current":-83.861681,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":28960917.86},{"date":"2021-08-13","current":-80.403466,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":27911893.15},{"date":"2021-08-20","current":-61.38329,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":20727360.57},{"date":"2021-08-27","current":-66.570612,"twenty":-61.834695,"median":-18.523034,"eighty":-5.327909,"marketCap":22871673.05},{"date":"2021-09-03","current":-77.809807,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":26985610.07},{"date":"2021-09-10","current":-70.893378,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24346632.12},{"date":"2021-09-17","current":-71.757932,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24430331.48},{"date":"2021-09-24","current":-73.487039,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":25125635.9},{"date":"2021-10-01","current":-18.935815,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24276713.03},{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-08-01","current":-1.062177,"twenty":-18.012117,"median":-1.178715,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-08","current":-1.08342,"twenty":-17.781192,"median":-1.163301,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-15","current":-1.08342,"twenty":-17.615217,"median":-1.153532,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-22","current":-1.062177,"twenty":-17.615217,"median":-1.142724,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-29","current":-1.08342,"twenty":-17.615217,"median":-1.133121,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-09-05","current":-1.083951,"twenty":-17.615217,"median":-1.119324,"eighty":-0.550857,"marketCap":5240049},{"date":"2025-09-12","current":-1.115286,"twenty":-17.615217,"median":-1.118135,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-09-19","current":-1.348445,"twenty":-17.589237,"median":-1.118135,"eighty":-0.550857,"marketCap":5466441},{"date":"2025-09-26","current":-1.429352,"twenty":-17.319343,"median":-1.118135,"eighty":-0.550857,"marketCap":5794427},{"date":"2025-10-03","current":-1.375414,"twenty":-16.996048,"median":-1.118135,"eighty":-0.550857,"marketCap":5575769},{"date":"2025-10-10","current":-1.29626,"twenty":-16.765124,"median":-1.118135,"eighty":-0.550857,"marketCap":5254889},{"date":"2025-10-17","current":-1.277382,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5178359},{"date":"2025-10-24","current":-1.324577,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5369684},{"date":"2025-10-31","current":-1.222905,"twenty":-15.610501,"median":-1.118135,"eighty":-0.550857,"marketCap":4957515},{"date":"2025-11-07","current":-0.999602,"twenty":-14.779173,"median":-1.11003,"eighty":-0.550857,"marketCap":4052272},{"date":"2025-11-14","current":-0.466831,"twenty":-14.455878,"median":-1.100951,"eighty":-0.550765,"marketCap":1892481},{"date":"2025-11-21","current":-0.268071,"twenty":-14.224953,"median":-1.099975,"eighty":-0.546197,"marketCap":1086728},{"date":"2025-11-28","current":-0.24222,"twenty":-14.086399,"median":-1.095371,"eighty":-0.543703,"marketCap":981932},{"date":"2025-12-05","current":-0.673835,"twenty":-13.62455,"median":-1.094042,"eighty":-0.543703,"marketCap":2731651},{"date":"2025-12-12","current":-1.06106,"twenty":-13.393625,"median":-1.088758,"eighty":-0.543703,"marketCap":4301415},{"date":"2025-12-19","current":-0.965609,"twenty":-13.162701,"median":-1.087521,"eighty":-0.543703,"marketCap":3914467},{"date":"2025-12-26","current":-0.84722,"twenty":-13.162701,"median":-1.085641,"eighty":-0.543703,"marketCap":3434532},{"date":"2026-01-02","current":-0.669637,"twenty":-12.700852,"median":-1.08342,"eighty":-0.543703,"marketCap":2714630},{"date":"2026-01-09","current":-0.899015,"twenty":-12.146632,"median":-1.08342,"eighty":-0.543703,"marketCap":3644504},{"date":"2026-01-16","current":-0.973008,"twenty":-11.587771,"median":-1.080702,"eighty":-0.543703,"marketCap":3944463},{"date":"2026-01-23","current":-1.049901,"twenty":-11.587771,"median":-1.079739,"eighty":-0.543703,"marketCap":4049449},{"date":"2026-01-30","current":-0.851586,"twenty":-11.587771,"median":-1.073308,"eighty":-0.543703,"marketCap":3284553},{"date":"2026-02-06","current":-0.563836,"twenty":-8.613576,"median":-1.072243,"eighty":-0.543703,"marketCap":2174704},{"date":"2026-02-13","current":-0.423849,"twenty":-8.613576,"median":-1.066619,"eighty":-0.541026,"marketCap":1634777},{"date":"2026-02-20","current":-0.577021,"twenty":-8.613576,"median":-1.066037,"eighty":-0.537847,"marketCap":2225559},{"date":"2026-02-27","current":-0.53514,"twenty":-8.613576,"median":-1.062177,"eighty":-0.536549,"marketCap":2064026},{"date":"2026-03-06","current":-0.502566,"twenty":-8.613576,"median":-1.05906,"eighty":-0.536549,"marketCap":1938390},{"date":"2026-03-13","current":-0.385627,"twenty":-4.943147,"median":-1.056151,"eighty":-0.53281,"marketCap":1487355},{"date":"2026-03-20","current":-0.206114,"twenty":-4.77165,"median":-1.051024,"eighty":-0.530164,"marketCap":1368585},{"date":"2026-03-27","current":-0.231847,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"marketCap":1539450}],"updateTime":1774866707839},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611738899","title":"Psychedelic: Clearmind reports additional CMND-100 safety results","url":"https://stock-news.laohu8.com/highlight/detail?id=2611738899","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611738899?lang=en_us&edition=fundamental","pubTime":"2026-02-12 23:40","pubTimestamp":1770910835,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on safety results, a CEO appointment...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-reports-additional-cmnd-100-safety-results-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-reports-additional-cmnd-100-safety-results-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2610651595","title":"BRIEF-Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile Of Cmnd-100 In Ongoing Phase I/Iia Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651595","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610651595?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:01","pubTimestamp":1770649315,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile Of Cmnd-100 In Ongoing Phase I/Iia Clinical TrialFeb 9 (Reuters) - Clearmind Medicine Inc CM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABXL8NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2610657653","title":"Clearmind Medicine Reports Positive Safety Results for CMND-100 in Alcohol Use Disorder Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610657653","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610657653?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:17","pubTimestamp":1770643033,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. has announced additional positive topline safety results from the second cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, a proprietary non-hallucinogenic MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder . The results, which have already been presented, indicate no serious adverse events and strong tolerability, consistent with findings from the first cohort. The multinational, multicenter study is assessing the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe AUD. The second cohort completed treatment at sites including Johns Hopkins University, Tel Aviv Sourasky Medical Center, and Hadassah Medical Center.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL8cyFWw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","NDAQ","BK4112","LU2210150020.SGD","SG9999014005.SGD","BK4007","LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","CMND","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4585","BK4588"],"gpt_icon":0},{"id":"2610653634","title":"Clearmind Medicine Inc - Safety Data Show No Serious Adverse Events in Second Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653634?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:17","pubTimestamp":1770643020,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABXL8NY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2610636653","title":"Clearmind Medicine Inc - Announces Positive Safety Results From Phase I/Iia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610636653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610636653?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:17","pubTimestamp":1770643020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABXL8NY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2610765653","title":"Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610765653","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610765653?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:17","pubTimestamp":1770643020,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, Feb.  09, 2026  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234516/0/en/Clearmind-Medicine-Announces-Additional-Topline-Positive-Safety-Results-Reinforcing-Favorable-Profile-of-CMND-100-in-Ongoing-Phase-I-IIa-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2609962715","title":"BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2609962715","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609962715?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:30","pubTimestamp":1770384643,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAIFeb 6 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND","PLRZ"],"gpt_icon":0},{"id":"2609596155","title":"BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596155","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609596155?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:25","pubTimestamp":1770384335,"startTime":"0","endTime":"0","summary":"BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery** Shares of drug developer Polyrizon PLRZ.O rise 12.6% to $14.00 premarket ** Co says it will develop an intranasal version of Clearmind’s CMND.O experimental MEAI therapy, being studied for addiction-related brain disorders** CNMD's shares were up 20% at $1.7 premarket** CNMD's MEAI is designed to reshape neural pathways without hallucinations; intranasal delivery may help faster absorption and bypass the liver, per co** Co says its gel-like nasal platform aims to keep drugs longer in the nose and improve targeted delivery** PLRZ shares down over 99%, CNMD down ~41% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z21E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4007","CMND"],"gpt_icon":0},{"id":"2609953545","title":"Clearmind Medicine Enters Into Development Agreement to Advance Intranasal Formulation for Its Proprietary Non-Hallucinogenic Neuroplastogen Meai","url":"https://stock-news.laohu8.com/highlight/detail?id=2609953545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609953545?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382530,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007","PLRZ"],"gpt_icon":0},{"id":"2609259539","title":"Polyrizon Partners with Clearmind to Develop Intranasal MEAI Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609259539","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609259539?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382510,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd., a pre-clinical-stage biotechnology company, has entered into a development agreement with Clearmind Medicine Inc., a clinical-stage biopharmaceutical firm. The collaboration focuses on developing a proprietary intranasal formulation of MEAI, Clearmind's next-generation, non-hallucinogenic neuroplastogen drug candidate aimed at treating addiction-related and other central nervous system conditions. Polyrizon will leverage its advanced intranasal delivery platform to enhance the clinical development of MEAI, offering targeted delivery and potentially faster absorption. The partnership is expected to support Clearmind's future clinical programs and highlights Polyrizon's expertise in specialized intranasal drug delivery solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL95mddZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","PLRZ","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BK4007","SG9999014005.SGD","CMND","BK4112","LU2210149790.SGD"],"gpt_icon":0},{"id":"2609595351","title":"Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595351?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA32DWG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND","PLRZ"],"gpt_icon":0},{"id":"2609431390","title":"Clearmind Medicine Issues $2.5 Million in Convertible Promissory Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2609431390","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609431390?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:17","pubTimestamp":1770239825,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. has announced the issuance and sale of convertible promissory notes to investors, as part of previously disclosed securities purchase agreements. The company will issue promissory notes in an aggregate principal amount of $2,500,000, with investors paying a total purchase price of $2,250,000 in cash . The offering will occur in two tranches: the first tranche, totaling $600,000 in principal for $540,000 in cash, closed on February 4, 2026. The second tranche, with a principal amount of $1,900,000 for $1,710,000 in cash, will close after Clearmind files a registration statement with the SEC covering the resale of shares issuable upon conversion of the notes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL4vD6pZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2609196313","title":"Clearmind Medicine gibt Ausgabe von Wandelanleihen im Gesamtwert von 2,5 Millionen US-Dollar bekannt","url":"https://stock-news.laohu8.com/highlight/detail?id=2609196313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609196313?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:17","pubTimestamp":1770239825,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL6KBF6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2608871679","title":"Clearmind Medicine welcomes inclusion of MEAI in bipartisan legislation","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608871679?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:15","pubTimestamp":1770124525,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) welcomes the inclusion of its proprietary compound, MEAI, in newly introduced bipartisan legislation in the U.S. Congress...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-welcomes-inclusion-of-meai-in-bipartisan-legislation-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-welcomes-inclusion-of-meai-in-bipartisan-legislation-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2608879372","title":"Clearmind Medicine erzielt Durchbruch mit MEAI in US-Gesetz für innovative Veteranen-Therapien","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879372","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879372?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123662,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL82sS3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","SG9999014039.USD","IE00BGHQF748.EUR","BK4585","CMND","IE00BKPKM429.USD","SG9999014021.USD","BK4007","NDAQ","BK4112"],"gpt_icon":0},{"id":"2603698116","title":"Psychedelic: Clearmind completes second cohort treatment for CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2603698116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603698116?lang=en_us&edition=fundamental","pubTime":"2026-01-15 23:40","pubTimestamp":1768491615,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on treatment completion, real world ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-second-cohort-treatment-for-cmnd-100-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-second-cohort-treatment-for-cmnd-100-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2603611416","title":"BRIEF-Clearmind Medicine Inc - Topline Results From Second Cohort Of CMND-100 Expected In Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611416","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603611416?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:02","pubTimestamp":1768399341,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Inc - Topline Results From Second Cohort Of CMND-100 Expected In Coming MonthsJan 14 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE INC - TOPLINE RESULTS FROM SE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2603761156","title":"Clearmind Medicine Inc - Topline Results From Second Cohort of Cmnd-100 Expected in Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2603761156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603761156?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:55","pubTimestamp":1768398956,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2603115786","title":"Clearmind Medicine Completes Second Cohort Treatment in Phase I/IIa Trial for Alcohol Use Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2603115786","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603115786?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:55","pubTimestamp":1768398914,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. has announced the successful completion of treatment for all patients in the second cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, an MEAI-based oral drug candidate for Alcohol Use Disorder . The multinational, multicenter study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe AUD. The second cohort, consisting of six patients across sites including Johns Hopkins University, Tel Aviv Sourasky Medical Center, and Hadassah Medical Center, has completed treatment per protocol. Topline results from the second cohort are expected to be presented in the coming months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL8BYjTh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210150020.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","CMND","SG9999014021.USD","BK4588","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4007","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014039.USD","BK4585","BK4112","LU2210149790.SGD","LU2095319765.USD"],"gpt_icon":0},{"id":"2603611650","title":"Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611650","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603611650?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:55","pubTimestamp":1768398900,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, Jan.  14, 2026  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218685/0/en/Clearmind-Medicine-Announces-Successful-Completion-of-Treatment-in-All-Patients-of-the-Second-Cohort-in-Ongoing-Phase-I-IIa-Clinical-Trial-for-CMND-100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":84,"code":"91000000","status":"200"}]}}